<?xml version="1.0" encoding="UTF-8"?>
<ref id="b0060">
 <label>12</label>
 <mixed-citation publication-type="other" id="h0060">Aeras. Results from innovative phase 2 tuberculosis vaccine trial offer potential for new BCG revaccination strategies, hope for subunit vaccines. &lt;
  <ext-link ext-link-type="uri" xlink:href="http://www.aeras.org/pressreleases/results-from-innovative-phase-2-tuberculosis-vaccine-trial-offer-potential%23.W1J609JKh9B" id="ir040" xmlns:xlink="http://www.w3.org/1999/xlink">http://www.aeras.org/pressreleases/results-from-innovative-phase-2-tuberculosis-vaccine-trial-offer-potential#.W1J609JKh9B</ext-link>&gt; [accessed February 14, 2019].
 </mixed-citation>
</ref>
